| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 07/13/2022 | — | HC Wainwright & Co. | Downgrades | Buy → Neutral | |
| 09/10/2021 | 201% | Jefferies | $37 → $9 | Downgrades | Buy → Hold |
| 09/09/2021 | — | JP Morgan | Downgrades | Neutral → Underweight | |
| 09/09/2021 | 836.45% | HC Wainwright & Co. | $36 → $28 | Maintains | Buy |
| 08/13/2021 | 702.68% | Credit Suisse | $25 → $24 | Maintains | Outperform |
| 08/10/2021 | 970.23% | Roth Capital | $37 → $32 | Maintains | Buy |
| 06/11/2021 | 836.45% | Credit Suisse | → $28 | Initiates Coverage On | → Outperform |
| 05/07/2021 | 903.34% | Oppenheimer | → $30 | Initiates Coverage On | → Outperform |
| 04/12/2021 | 1104.01% | HC Wainwright & Co. | $34 → $36 | Reiterates | → Buy |
| 12/23/2020 | 1070.57% | National Securities Corporation | → $35 | Initiates Coverage On | → Buy |
| 12/22/2020 | 803.01% | Jefferies | → $27 | Initiates Coverage On | → Buy |
| 10/21/2020 | 736.12% | Cantor Fitzgerald | → $25 | Initiates Coverage On | → Overweight |
| 10/14/2020 | 936.79% | HC Wainwright & Co. | → $31 | Initiates Coverage On | → Buy |
| 10/01/2020 | 736.12% | Roth Capital | → $25 | Initiates Coverage On | → Buy |
Humanigen Questions & Answers
The latest price target for Humanigen (NASDAQ: HGEN) was reported by HC Wainwright & Co. on July 13, 2022. The analyst firm set a price target for $0.00 expecting HGEN to fall to within 12 months (a possible -100.00% downside). 6 analyst firms have reported ratings in the last year.
The latest analyst rating for Humanigen (NASDAQ: HGEN) was provided by HC Wainwright & Co., and Humanigen downgraded their neutral rating.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Humanigen, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Humanigen was filed on July 13, 2022 so you should expect the next rating to be made available sometime around July 13, 2023.
While ratings are subjective and will change, the latest Humanigen (HGEN) rating was a downgraded with a price target of $0.00 to $0.00. The current price Humanigen (HGEN) is trading at is $2.99, which is out of the analyst's predicted range.